Treatment for breast cancer can come in many forms. In addition to surgery to remove cancerous tissue and radiation therapy, breast cancer is also commonly treated with drugs that are taken orally or ...

Research has shown that women treated for early-stage ER-positive breast cancer benefit from receiving at least 5 years of adjuvant hormone therapy. 3 Adjuvant therapy is treatment given after the ...

Discover the latest advancements in breast cancer treatment from leading experts in surgery, radiation and reconstruction. Your world shatters when you hear the words, “You have breast cancer.” You ...

For women with early-stage breast cancer, breast-conserving therapy (BCT)—including radiation therapy (RT)—leads to progressive reduction in breast size over time, reports a study in Plastic and ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone-blocking treatments crucial. Diagnosis ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted cancer drug offers a superior first-line treatment for aggressive ...

MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...

After you’re diagnosed with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer, your doctor’s goal is to build a treatment plan that gives you the best chance of controlling your ...

HER2 normally helps control the growth and repair of your cells, but too much of it can trigger HER2-positive cancer to develop. Generally, HER2-negative breast cancers tend to be less aggressive and ...

Jennifer Deming, 60, was diagnosed with stage II, hormone receptor-positive, HER2-negative breast cancer in 2020. She opted for a double mastectomy. Still, she worried about the cancer coming back. “I ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy ...